BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stinghen AE, Pecoits-Filho R. Vascular damage in kidney disease: beyond hypertension. Int J Hypertens 2011;2011:232683. [PMID: 21876786 DOI: 10.4061/2011/232683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Rempel LC, Finco AB, Maciel RA, Bosquetti B, Alvarenga LM, Souza WM, Pecoits-Filho R, Stinghen AE. Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs). Toxins (Basel) 2015;7:1722-37. [PMID: 26008233 DOI: 10.3390/toxins7051722] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
2 Papazova DA, Krebber MM, Oosterhuis NR, Gremmels H, van Zuilen AD, Joles JA, Verhaar MC. Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation. Dis Model Mech 2018;11:dmm035030. [PMID: 30038062 DOI: 10.1242/dmm.035030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tasic D, Radenkovic S, Kocic G, Ilic MD, Ignjatovic A. Microinflammation factors in the common diseases of the heart and kidneys. Dis Markers 2015;2015:470589. [PMID: 25648331 DOI: 10.1155/2015/470589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lin YT, Wu PH, Tsai YC, Hsu YL, Wang HY, Kuo MC, Kuo PL, Hwang SJ. Indoxyl Sulfate Induces Apoptosis Through Oxidative Stress and Mitogen-Activated Protein Kinase Signaling Pathway Inhibition in Human Astrocytes. J Clin Med 2019;8:E191. [PMID: 30764571 DOI: 10.3390/jcm8020191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
5 Shen Z, Ruan Q, Yu Z, Sun Z. Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review. Geriatr Gerontol Int 2017;17:529-44. [PMID: 27240548 DOI: 10.1111/ggi.12758] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
6 Bobot M, Thomas L, Moyon A, Fernandez S, McKay N, Balasse L, Garrigue P, Brige P, Chopinet S, Poitevin S, Cérini C, Brunet P, Dignat-George F, Burtey S, Guillet B, Hache G. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction. J Am Soc Nephrol 2020;31:1509-21. [PMID: 32527975 DOI: 10.1681/ASN.2019070728] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
7 Kelly DM, Rothwell PM. Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders. Front Neurol 2022;13:830064. [DOI: 10.3389/fneur.2022.830064] [Reference Citation Analysis]
8 Luczak M, Suszynska-Zajczyk J, Marczak L, Formanowicz D, Pawliczak E, Wanic-Kossowska M, Stobiecki M. Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease. Int J Mol Sci 2016;17:E631. [PMID: 27144566 DOI: 10.3390/ijms17050631] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sheshadri A, Kittiskulnam P, Lazar AA, Johansen KL. A Walking Intervention to Increase Weekly Steps in Dialysis Patients: A Pilot Randomized Controlled Trial. Am J Kidney Dis 2020;75:488-96. [PMID: 31679747 DOI: 10.1053/j.ajkd.2019.07.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
10 Wang H, Peng W, Shen X, Huang Y, Ouyang X, Dai Y. Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease. Braz J Med Biol Res 2012;45:1308-14. [PMID: 23070235 DOI: 10.1590/s0100-879x2012007500165] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
11 Chen J, Pan H, Lanza GM, Wickline SA. Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy. Adv Chronic Kidney Dis 2013;20:466-78. [PMID: 24206599 DOI: 10.1053/j.ackd.2013.08.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
12 Chen YC, Weng SC, Liu JS, Chuang HL, Hsu CC, Tarng DC. Severe Decline of Estimated Glomerular Filtration Rate Associates with Progressive Cognitive Deterioration in the Elderly: A Community-Based Cohort Study. Sci Rep 2017;7:42690. [PMID: 28209982 DOI: 10.1038/srep42690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
13 Kruse NT. Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD. Am J Physiol Regul Integr Comp Physiol 2019;317:R719-32. [PMID: 31577157 DOI: 10.1152/ajpregu.00152.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 McManus DD, Saczynski JS, Ward JA, Jaggi K, Bourrell P, Darling C, Goldberg RJ. The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic. J Atr Fibrillation. 2012;5:442. [PMID: 28496745 DOI: 10.4022/jafib.442] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Toyoda G, Bokura H, Mitaki S, Onoda K, Oguro H, Nagai A, Yamaguchi S. Association of mild kidney dysfunction with silent brain lesions in neurologically normal subjects. Cerebrovasc Dis Extra 2015;5:22-7. [PMID: 25873927 DOI: 10.1159/000373916] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
16 Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Okita K, Iwahashi H, Ohira T, Imagawa A, Nakamura T, Shimomura I. Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study. Nutr Metab (Lond) 2011;8:82. [PMID: 22108213 DOI: 10.1186/1743-7075-8-82] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
17 Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 2013;24:353-63. [PMID: 23291474 DOI: 10.1681/ASN.2012050536] [Cited by in Crossref: 271] [Cited by in F6Publishing: 140] [Article Influence: 30.1] [Reference Citation Analysis]
18 Paterson EN, Ravindran ML, Griffiths K, Le Velly CA, Cardwell CC, McCarter RV, Nicol P, Chhablani JK, Rasheed MA, Vupparaboina KK, MacGillivray TJ, Harbinson M, Maxwell AP, Hogg RE, McKay GJ. Association of reduced inner retinal thicknesses with chronic kidney disease. BMC Nephrol 2020;21:37. [PMID: 32005180 DOI: 10.1186/s12882-019-1679-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Franco ÁO, Starosta RT, Roriz-Cruz M. The specific impact of uremic toxins upon cognitive domains: a review. J Bras Nefrol 2019;41:103-11. [PMID: 30095142 DOI: 10.1590/2175-8239-JBN-2018-0033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 van Rhijn-Brouwer FCC, van Balkom BWM, Papazova DA, Hazenbrink DHM, Meijer AJ, Brete I, Briceno V, van Zuilen AD, Toorop RJ, Fledderus JO, Gremmels H, Verhaar MC. Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease. Stem Cells Int 2019;2019:1232810. [PMID: 31933648 DOI: 10.1155/2019/1232810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Heo CM, Lee WH, Park BS, Lee YJ, Park S, Kim YW, Lee DA, Yoo BC, Park KM. Glymphatic Dysfunction in Patients With End-Stage Renal Disease. Front Neurol 2022;12:809438. [DOI: 10.3389/fneur.2021.809438] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Brito RBO, Rebello JF, Grabulosa CC, Pinto W, Morales A Jr, Elias RM, Moyses RMA, Dalboni MA. 25-vitamin D reduces inflammation in uremic environment. Sci Rep 2020;10:128. [PMID: 31924826 DOI: 10.1038/s41598-019-56874-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Kopel T, Kaufman JS, Hamburg N, Sampalis JS, Vita JA, Dember LM. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease. Clin J Am Soc Nephrol 2017;12:1588-94. [PMID: 28784655 DOI: 10.2215/CJN.12811216] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 6.2] [Reference Citation Analysis]